The global HDAC inhibitor market is gaining significant momentum as the healthcare industry continues to advance targeted therapies for cancer and other complex diseases. Histone deacetylase (HDAC) inhibitors are a class of compounds that regulate gene expression by altering chromatin structure, making them valuable in the treatment of various malignancies and epigenetic disorders. The...
Executive Summary RNA-Based Cancer Therapeutics Market Size and Share Across Top Segments
CAGR Value
The global RNA-based cancer therapeutics market size was valued at USD 415.8 million in 2025 and is expected to reach USD 947.1 million by 2033, at a CAGR of 10.80% during the forecast period
Market drivers and market restraints covered in this...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek